Calyxt (NASDAQ:CLXT) Releases Earnings Results, Beats Expectations By $0.03 EPS

Calyxt (NASDAQ:CLXTGet Rating) introduced its quarterly earnings results on Thursday. The company documented ($.14) earnings per share for the quarter, beating analysts’ consensus estimates of ($.17) by $.03, MarketWatch Earnings stories. Calyxt had a damaging web margin of 112.36% and a damaging return on equity of 169.93%. Throughout the identical time period in the prior yr, the company posted ($.24) EPS.

CLXT stock traded down $.07 during mid-working day buying and selling on Friday, hitting $.32. 1,145,252 shares of the business ended up exchanged, as opposed to its normal quantity of 703,819. The firm has a sector cap of $13.47 million, a P/E ratio of -.49 and a beta of 2.12. The enterprise has a financial debt-to-equity ratio of 1.24, a fast ratio of 3.13 and a current ratio of 3.13. The firm’s 50 working day straightforward transferring common is $.84 and its 200 day uncomplicated transferring regular is $1.82. Calyxt has a 1-yr lower of $.31 and a 1-year higher of $5.42.

Independently, Canaccord Genuity Group dropped their target price tag on shares of Calyxt from $6.00 to $4.00 and established a “buy” ranking on the inventory in a report on Friday, March 4th.

Huge buyers have not long ago additional to or minimized their stakes in the firm. Dimensional Fund Advisors LP grew its holdings in shares of Calyxt by 99.2% throughout the fourth quarter. Dimensional Fund Advisors LP now owns 24,980 shares of the company’s inventory well worth $53,000 after obtaining an additional 12,441 shares during the final quarter. Morgan Stanley grew its holdings in shares of Calyxt by 30.7% through the 1st quarter. Morgan Stanley now owns 15,512 shares of the company’s inventory worth $93,000 just after purchasing an more 3,646 shares throughout the very last quarter. Financial institution of New York Mellon Corp purchased a new stake in shares of Calyxt throughout the 3rd quarter worth about $96,000. JPMorgan Chase & Co. grew its holdings in shares of Calyxt by 67.8% through the fourth quarter. JPMorgan Chase & Co. now owns 49,909 shares of the company’s inventory really worth $106,000 just after paying for an more 20,160 shares all through the very last quarter. Finally, Marshall Wace LLP grew its holdings in shares of Calyxt by 33.2% in the course of the fourth quarter. Marshall Wace LLP now owns 84,574 shares of the company’s stock really worth $180,000 right after buying an additional 21,095 shares during the previous quarter. Institutional traders have 22.98% of the company’s stock.

Calyxt Organization Profile (Get Ranking)

Calyxt, Inc, a synthetic biology business, engages in delivering plant-dependent solutions principally to the agriculture conclude marketplace in the United States. The firm is associated in the development of enhanced digestibility alfalfa hemp and wheat with a bigger fiber written content. It has a commercialization agreement with S&W Seed Company for the unique license of an enhanced quality alfalfa seed in the United States and internationally.

Featured Content articles

Earnings History for Calyxt (NASDAQ:CLXT)

Want Much more Fantastic Investing Ideas?

Obtain Information & Scores for Calyxt Every day – Enter your email address under to get a concise every day summary of the newest news and analysts’ scores for Calyxt and similar providers with MarketBeat.com’s Totally free day-to-day email newsletter.